David Cleevely is a CoFounder of Cambridge Angels, a UK-based angel group he helped establish in 1999. See portfolio, sector focus and contact routes.
David Cleevely is a CoFounder of Cambridge Angels, a UK-based angel group he helped establish in 1999 alongside entrepreneurs like Doug Richard and Sherry Coutu, drawing on his 30+ years as a serial entrepreneur in bio and high-tech ventures such as Abcam and Analysys. His investment thesis targets early-stage technology businesses, with Cambridge Angels focusing on seed, venture, and early-to-late stage deals primarily in internet, software, technology, and biotechnology sectors across Europe. While his personal typical check size and lead/follow behavior are not publicly specified, he has invested in over 35 companies and chairs four, indicating active involvement. Notable portfolio companies include Abcam (sold for $6 billion in 2024), the Raspberry Pi Foundation, Thought Machine, and Axol Bioscience. Cleevely distinguishes himself through public advocacy for long-term strategy in entrepreneurship and has authored work emphasizing that “serendipity doesn’t happen by accident,” while also serving as a policy adviser and holding a CBE for services to technology and innovation.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Cambridge when building a target list.
Investors like David Cleevely · Full investor directory · Investor access · Company funding database